Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34724386

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Dec 10
First author
Santomasso BD

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 May 1;40(13):1508-1509. doi: 10.1200/JCO.21.02694.
    note
    Source null
    related pmid
    35245082
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 May 1;40(13):1509. doi: 10.1200/JCO.22.00225.
    note
    Source null
    related pmid
    35245095
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Mar 10;40(8):919. doi: 10.1200/JCO.22.00279.
    note
    Source null
    related pmid
    35255231
    relationship
    Erratum in

Authors and identifiers

  1. name
    Santomasso BD
    type
    Author
  2. name
    Nastoupil LJ
    type
    Author
  3. name
    Adkins S
    type
    Author
  4. name
    Lacchetti C
    type
    Author
  5. name
    Schneider BJ
    type
    Author
  6. name
    Anadkat M
    type
    Author
  7. name
    Atkins MB
    type
    Author
  8. name
    Brassil KJ
    type
    Author
  9. name
    Caterino JM
    type
    Author
  10. name
    Chau I
    type
    Author
  11. name
    Davies MJ
    type
    Author
  12. name
    Ernstoff MS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Santomasso BD
    type
    Author
  2. name
    Nastoupil LJ
    type
    Author
  3. name
    Adkins S
    type
    Author
  4. name
    Lacchetti C
    type
    Author
  5. name
    Schneider BJ
    type
    Author
  6. name
    Anadkat M
    type
    Author
  7. name
    Atkins MB
    type
    Author
  8. name
    Brassil KJ
    type
    Author
  9. name
    Caterino JM
    type
    Author
  10. name
    Chau I
    type
    Author
  11. name
    Davies MJ
    type
    Author
  12. name
    Ernstoff MS
    type
    Author
bibliography ids
  1. nci-bib-8ec72e9b1bbddd28539d66e2
book metadata
content sha256
ba03a253afce5a23574c8228b96a7f3086050235a58a9d54b841660a7e45ae77
document type
citation
dois
  1. 10.1200/JCO.21.01992
electronic publication date
display
2021 Nov 1
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34724386
immutable id
pubmed:34724386@ba03a253afce5a23574c8228b96a7f3086050235a58a9d54b841660a7e45ae77
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
35
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3978-3992
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 May 1;40(13):1508-1509. doi: 10.1200/JCO.21.02694.
    note
    Source null
    related pmid
    35245082
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 May 1;40(13):1509. doi: 10.1200/JCO.22.00225.
    note
    Source null
    related pmid
    35245095
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Mar 10;40(8):919. doi: 10.1200/JCO.22.00279.
    note
    Source null
    related pmid
    35255231
    relationship
    Erratum in
outcomes validated
false
pmid
34724386
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
1bebcc7cbbc17a0533d79ef6d5a08f82797cefac981c5529bea7aca96c7210a6
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2021 Dec 10
precision
day
year
2021
publication types
  1. Journal Article
  2. Systematic Review
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34724386/
title
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Preserved source evidence · Independent clinical review pending · Not medical advice